Cargando…
Selective serotonin reuptake inhibitors for functional independence and depression prevention in early stage of post-stroke: A meta-analysis
BACKGROUND: The efficacy and safety of selective serotonin reuptake inhibitors (SSRIs) for functional independence and depression prevention in early stage of post-stroke (within 1 month after stroke onset) are still unclear. METHODS: Relevant randomized controlled trials (RCTs) comparing early SSRI...
Autores principales: | Zhou, Shaojiong, Liu, Shuo, Liu, Xiaoqiang, Zhuang, Weiduan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015581/ https://www.ncbi.nlm.nih.gov/pubmed/32028426 http://dx.doi.org/10.1097/MD.0000000000019062 |
Ejemplares similares
-
Association between red cell distribution width level and risk of stroke: A systematic review and meta-analysis of prospective studies
por: Li, Bingxian, et al.
Publicado: (2020) -
Effect of selective serotonin reuptake inhibitor treatment on the prognosis of patients with medication overuse headache
por: Fang, Jinghuan, et al.
Publicado: (2018) -
In-hospital predictors of post-stroke depression for targeted initiation of Selective Serotonin Reuptake Inhibitors (SSRIs)
por: Yi, Julie, et al.
Publicado: (2022) -
Rapid response to selective serotonin reuptake inhibitors in post-COVID depression
por: Mazza, Mario Gennaro, et al.
Publicado: (2022) -
Improvement of Post Stroke Echolalia after Using Selective Serotonin Reuptake Inhibitors
por: Bae, Heewon, et al.
Publicado: (2019)